Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

eCQM Concepts filtered by: Clinicians Office

Actionable Biomarkers Determined from Broad Molecular Testing for Patients with Stage IV Non-small Cell Lung Cancer (NSCLC) to Inform Targeted Therapy

eCQM Concept -
(Last updated: Apr 15, 2024)
This measure would calculate the rate of cases where actionable biomarkers for targeted therapy are identified through repeat molecular tests ordered by the provider due to inadequate tissue samples (as determined by the pathologist or receiving physician) for patients with Stage IV NSCLC and…

Appropriate Biomarker/Molecular Testing Based on Available Evidence for Patients with Stage IV Non-small Cell Lung Cancer (NSCLC)

eCQM Concept -
(Last updated: Apr 15, 2024)
In alignment with NCCN guidelines,[1] this measure would calculate the percentage of patients with Stage IV NSCLC and established histological subtypes who receive biomarker/molecular testing for a broad panel of actionable biomarkers as their initial genomic test as opposed to single gene testing…

Supporting Access to Biomarker/Molecular Testing Among Patients with, or at Risk for, High-Burden Cancers

eCQM Concept -
(Last updated: Apr 15, 2024)
This measure would calculate the percentage of patients with a cancer diagnosis and/or increased risk of high-burden cancers (NSCLC, breast, colorectal, cervical, prostate) eligible for guideline-recommended biomarker/molecular testing options who (1) were screened for the 5 domains of social…
Subscribe to s filtered by: <strong>Clinicians Office</strong>